375 studies found for:    "Abdominal Neoplasms"
Show Display Options
Rank Status Study
1 Recruiting Malignant Pediatric Pelvic Tumors: A Retrospective Study
Conditions: Abdominal Neoplasms;   Pelvic Neoplasms
Intervention:
2 Completed Determination of a Safe Dose of Optison in Pediatric Patients With Solid Tumors
Conditions: Abdominal Neoplasms;   Pelvic Neoplasms
Intervention: Drug: Optison
3 Unknown  Nutritional Supplementation in Patients With no Signs of Malnutrition
Conditions: Primary Neoplasm;   Secondary Neoplasm;   Abdominal Neoplasm
Intervention: Dietary Supplement: Nutritional supplements
4 Completed
Has Results
Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy
Conditions: Abdominal Neoplasm;   Colonic Neoplasm;   Mesothelioma;   Peritoneal Neoplasm
Interventions: Procedure: Surgery;   Procedure: Continuous hyperthermic peritoneal perfusion (CHPP) with Cisplatin;   Drug: Postoperative dwell with paclitaxel and 5-FU
5 Recruiting Augmented Pulse Pressure Variation to Predict Fluid Responsiveness in Open Laparotomy
Conditions: Gynecologic Neoplasms;   Abdominal Neoplasms
Interventions: Other: Augmented ventilation;   Other: Fluid loading
6 Recruiting EUS GUIDED Transduodenal Biopsy Using the 19G Flex
Condition: Abdominal Neoplasms
Intervention: Device: Expect™19Flex needle (Boston Scientific Corp.,Natick,MA,USA)
7 Completed Restricted Intravenous Fluid Regime Effects on Immunological Indicators of Elderly Patients Operated for Abdominal Cancer
Conditions: Surgery;   Perioperative Care;   Immunization;   Abdominal Neoplasms
Interventions: Behavioral: perioperative fluid management;   Behavioral: perioperative fluid treatment
8 Completed Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer Surgery
Condition: Abdominal Neoplasms
Interventions: Drug: enoxaparin;   Other: Physical prophylaxis
9 Unknown  Comparison the Hemodynamics Effects Between Dexmedetomidine and Propofol in Major Abdominal Surgical Patients
Conditions: Abdominal Tumor;   Intestinal Obstruction;   Cirrhosis;   Intestinal Fistula;   Aneurism
Interventions: Drug: dexmedetomidine;   Drug: propofol
10 Recruiting Evaluation of Continuous Positive Airway Pressure for Tumor Motion Management in Radiotherapy
Conditions: Tumor Motion;   "Continuous Positive Airway Pressure";   Lung Cancer;   Breast Cancer;   Abdominal Tumors
Intervention: Device: Continuous positive airway pressure (CPAP)
11 Recruiting TAP Versus Thoracic Epidural in Major Abdominal Resections
Conditions: Malignant Neoplasm of Abdomen;   Surgery
Interventions: Drug: Exparel 1.33% (20ml Volume);   Drug: 0.125% bupivicaine with 2 mcg/ml Fentanyl.
12 Recruiting Efficacy of Transverses Abdominis -Plane Block With Bupivacaine Versus Bupivacaine With Morphine Postoperatively
Condition: Abdominal Cancer
Intervention: Drug: transversus abdominis-plane block with local anesthetic 20 ml of bupivacaine 0.5% + 10 mg morphine
13 Completed Effects of Dexmedetomidine During Radiofrequency Ablation of Abdominal Tumours
Conditions: Cancer of Kidney and Renal Pelvis;   Cancer of Liver
Intervention: Drug: Dexmedetomidine
14 Not yet recruiting Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors
Conditions: Small Cell Lung Carcinoma;   Carcinoma, Squamous Cell of Head and Neck;   Stomach Neoplasms;   Triple Negative Breast Neoplasms;   Ovarian Neoplasms;   Fallopian Tube Neoplasms;   Peritoneal Neoplasms;   Esophagogastric Junction Neoplasms
Interventions: Drug: paclitaxel + carboplatin;   Drug: carboplatin + etoposide;   Drug: gemcitabine + carboplatin;   Drug: nab-paclitaxel (paclitaxel-albumin) + carboplatin;   Drug: oxaliplatin + 5-fluorouracil (5FU) + leucovorin (calcium folinate/folinic acid);   Biological: durvalumab;   Biological: tremelimumab
15 Completed Local mEHT + TCM Versus Intraperitoneal Chemoinfusion in Treatment of Malignant Ascites: Phase II RCT
Conditions: Peritoneal Neoplasms;   Ascites;   Yang Deficiency;   Yin Deficiency
Interventions: Device: Modulated Electro-Hyperthermia (mEHT);   Dietary Supplement: TCM Herbal Decoction (Shi Pi);   Drug: IPCI (CDDP+5FU)
16 Recruiting Study of IMGN853 in Comb. With Bevacizumab, Carboplatin or PLD in Adults With FRa + Adv. EOC, Primary Peritoneal, Fallopian Tube, or Endometrial Cancer
Conditions: Epithelial Ovarian Cancer;   Primary Peritoneal Cancer;   Fallopian Tube Cancer;   Endometrial Cancer
Interventions: Drug: IMGN853;   Drug: Bevacizumab;   Drug: Carboplatin;   Drug: Doxorubicin
17 Recruiting Trial of Nilotinib and Adriamycin as Treatment in Liposarcomas and Leiomyosarcomas of Retroperitoneum
Conditions: Retroperitoneal Liposarcoma;   Retroperitoneal Leiomyosarcoma;   Chondrosarcoma
Intervention: Drug: Nilotinib-adriamycin
18 Recruiting Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic Malignancies
Conditions: Cervical Carcinoma;   Ovarian Carcinoma;   Primary Peritoneal Carcinoma;   Recurrent Cervical Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Uterine Corpus Carcinoma;   Recurrent Vulvar Carcinoma;   Uterine Corpus Cancer;   Vulvar Carcinoma;   Peritoneal Neoplasms
Interventions: Other: Palliative Therapy;   Other: Palliative Therapy + idiographic
19 Not yet recruiting Safety and Efficacy of CRS-207 With Epacadostat in Platinum Resistant Ovarian, Fallopian, or Peritoneal Cancer
Conditions: Platinum-resistant Ovarian Cancer;   Platinum-resistant Fallopian Cancer;   Platinum-resistant Peritoneal Cancer
Interventions: Biological: CRS-207;   Drug: epacadostat (INCB024360)
20 Not yet recruiting PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer;   Peritoneal Neoplasms
Interventions: Drug: Olaparib;   Drug: Tremelimumab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years